RDInvesting Provides Investors with Free In-Depth Equity Reports on BRKR, ESPR, KTOS and NSTG
Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.
Bruker Corporation (NASDAQ: BRKR) shares increased 3.15 percent to close at $18.03 a share Monday. The stock traded between $17.72 and $18.27 on volume of 1.06 million shares traded. Analysts at Cowen have recently initiated coverage on the company with a “outperform” rating. Shares of Bruker have gained over 18.0 percent year-to-date.
Find out more about Bruker including full access to the free equity report at:
www.RDInvesting.com/BRKR
Esperion Therapeutics Inc. (NASDAQ: ESPR) shares gained 0.89 percent to close at $17.05 a share Monday. The stock traded between $16.87 and $17.89 on volume of 350,105 shares traded. Analysts at Citigroup have recently initiated coverage on the company with a “buy” rating. Shares of Esperion Therapeutics have gained approximately 17.5 percent year-to-date.
Find out more about Esperion Therapeutics including full access to the free equity report at:
www.RDInvesting.com/ESPR
Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) shares declined 1.70 percent to close at $6.92 a share Monday. The stock traded between $6.89 and $7.10 on volume of 505,262 shares traded. Analysts at Jefferies have recently initiated coverage on the company with a “hold” rating. Shares of Kratos have gained approximately 17.5 percent year-to-date.
Find out more about Kratos including full access to the free equity report at:
www.RDInvesting.com/KTOS
NanoString Technologies Inc. (NASDAQ: NSTG) shares declined 1.80percent to close at $9.27 a share Monday. The stock traded between $9.07 and $9.64 on volume of 211,665 shares traded. Analysts at Morgan Stanley have recently initiated coverage on the company with an “overweight” rating. Shares of NanoString Technologies have gained approximately 15.0 percent year-to-date.
Find out more about NanoString Technologies including full access to the free equity report at:
www.RDInvesting.com/NSTG
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Research Driven Investing
info@rdinvesting.com